Evidence map›Paper›PMID 38921737›Full record

ArticlePathogens (Basel, Switzerland)2024

Characterization of CRISPR-Cas Systems in

Jui-Hsing Wang, Po-Tsang Huang, Yao-Ting Huang, Yan-Chiao Mao, Chung-Hsu Lai, Ting-Kuang Yeh, Chien-Hao Tseng, Chih-Chuan Kao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jui-Hsing WangDivision of Infectious Disease, Department of Internal Medicine, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung 427213, Taiwan.ORCID 0000-0002-6367-3160
Po-Tsang HuangDivision of Pharmacy, Kaohsiung Armed Forces General Hospital, Kaohsiung 802301, Taiwan.
Yao-Ting HuangDepartment of Computer Science and Information Engineering, National Chung Cheng University, Chia-Yi 621301, Taiwan.ORCID 0000-0001-9253-2394
Yan-Chiao MaoDivision of Clinical Toxicology, Department of Emergency Medicine, Taichung Veterans General Hospital, Taichung 407219, Taiwan.ORCID 0000-0002-8561-0582
Chung-Hsu LaiDivision of Infectious Diseases, Department of Internal Medicine, E-Da Hospital, Kaohsiung 824005, Taiwan.
Ting-Kuang YehDivision of Infectious Diseases, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 407219, Taiwan.ORCID 0000-0001-5540-4780
Chien-Hao TsengDivision of Infectious Diseases, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 407219, Taiwan.ORCID 0000-0003-2098-8872
Chih-Chuan KaoDivision of Infectious Disease, Department of Internal Medicine, Tungs' Taichung Metroharbor Hospital, Taichung 435403, Taiwan.

Funding

National Science and Technology Council 109-2221-E-194 -038 -MY3 and 111-2221-E-194-031-MY3
6 · The paper itself

Abstract

CRISPR-Cas systems are adaptive immune mechanisms present in most prokaryotes that play an important role in the adaptation of bacteria and archaea to new environments.

Indexed as

CRISPR-Cas SystemsGenome, BacterialShewanellaAdaptation, PhysiologicalAquatic OrganismsPhylogenyWhole Genome SequencingCRISPR–CasShewanellawhole-genome sequencing

Identifiers

PMID38921737
PMCPMC11207072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.